skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
12
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

ARMAND, Philippe ; NAGLER, Arnon ; FAY, Joseph W ; RIZZIERI, David A ; HOSING, Chitra M ; BALL, Edward D ; UBERTI, Joseph P ; LAZARUS, Hillard M ; MAPARA, Markus Y ; GREGORY, Stephanie A ; TIMMERMAN, John M ; ANDORSKY, David ; WELLER, Edie A ; OR, Reuven ; WALLER, Edmund K ; ROTEM-YEHUDAR, Rinat ; GORDON, Leo I ; DEVINE, Steven M ; AVIGAN, David E ; CHEN, Yi-Bin ; KAMINSKI, Mark S ; KENT HOLLAND, H ; WINTER, Jane N ; MASON, James R

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
13
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies

Rizzieri, David A ; Feldman, Eric ; Dipersio, John F ; Gabrail, Nashat ; Stock, Wendy ; Strair, Roger ; Rivera, Victor M ; Albitar, Maher ; Bedrosian, Camille L ; Giles, Francis J

Clinical cancer research, 2008-05, Vol.14 (9), p.2756-2762 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
14
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

Issa, Jean-Pierre J, Prof ; Roboz, Gail, Prof ; Rizzieri, David, Prof ; Jabbour, Elias, MD ; Stock, Wendy, Prof ; O'Connell, Casey, MD ; Yee, Karen, MD ; Tibes, Raoul, MD ; Griffiths, Elizabeth A, MD ; Walsh, Katherine, MD ; Daver, Naval, MD ; Chung, Woonbok, PhD ; Naim, Sue, BS ; Taverna, Pietro, PhD ; Oganesian, Aram, PhD ; Hao, Yong, MD ; Lowder, James N, MD ; Azab, Mohammad, MD ; Kantarjian, Hagop, Prof

The lancet oncology, 2015-09, Vol.16 (9), p.1099-1110 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
15
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration

HORWITZ, M. E ; CHUTE, J. P ; GASPARETTO, C ; LONG, G. D ; MCDONALD, C ; MORRIS, A ; RIZZIERI, D. A ; SULLIVAN, K. M ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-08, Vol.47 (8), p.1051-1055 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
16
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

DUVAL, Michel ; KLEIN, John P ; KEATING, Armand ; LAZARUS, Hillard M ; LITZOW, Mark R ; MARKS, David I ; MAZIARZ, Richard T ; RIZZIERI, David A ; SCHILLER, Gary ; SCHULTZ, Kirk R ; TALLMAN, Martin S ; WEISDORF, Daniel ; WENSHENG HE ; CAHN, Jean-Yves ; CAIRO, Mitchell ; CAMITTA, Bruce M ; KAMBLE, Rammurti ; COPELAN, Edward ; DE LIMA, Marcos ; GUPTA, Vikas

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3730-3738 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
17
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

Dannull, Jens ; Su, Zhen ; Rizzieri, David ; Yang, Benjamin K ; Coleman, Doris ; Yancey, Donna ; Zhang, Aijing ; Dahm, Philipp ; Chao, Nelson ; Gilboa, Eli ; Vieweg, Johannes

The Journal of clinical investigation, 2005-12, Vol.115 (12), p.3623-3633 [Periódico revisado por pares]

United States: American Society for Clinical Investigation

Texto completo disponível

Citações Citado por
18
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia

Giles, F J ; Swords, R T ; Nagler, A ; Hochhaus, A ; Ottmann, O G ; Rizzieri, D A ; Talpaz, M ; Clark, J ; Watson, P ; Xiao, A ; Zhao, B ; Bergstrom, D ; Le Coutre, P D ; Freedman, S J ; Cortes, J E

Leukemia, 2013-01, Vol.27 (1), p.113-117 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
19
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation

KANDA, J ; HORWITZ, M. E ; RIZZIERI, D. A ; LONG, G. D ; GASPARETTO, C ; SULLIVAN, K. M ; CHUTE, J. P ; MORRIS, A ; HENNIG, T ; LI, Z ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.700-705 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
20
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML
Material Type:
Artigo 		Adicionar ao Meu Espaço

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML

Sorror, Mohamed L. ; Gooley, Ted A. ; Storer, Barry E. ; Gerds, Aaron T. ; Sekeres, Mikkael A. ; Medeiros, Bruno C. ; Wang, Eunice S. ; Shami, Paul J. ; Adekola, Kehinde ; Luger, Selina ; Baer, Maria R. ; Rizzieri, David A. ; Wildes, Tanya M. ; Koprivnikar, Jamie ; Smith, Julie ; Garrison, Mitchell ; Kojouri, Kiarash ; Schuler, Tammy A. ; Leisenring, Wendy M. ; Onstad, Lynn E. ; Becker, Pamela S. ; McCune, Jeannine S. ; Lee, Stephanie J. ; Sandmaier, Brenda M. ; Appelbaum, Frederick R. ; Estey, Elihu H.

Blood, 2023-01, Vol.141 (3), p.295-308 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (497)

Data de Publicação 

De até
Refinar
  1. Antes de2002  (10)
  2. 2002Até2006  (55)
  3. 2007Até2011  (136)
  4. 2012Até2017  (242)
  5. Após 2017  (98)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (539)
  2. Japonês  (79)
  3. Português  (2)
  4. Francês  (1)
  5. Espanhol  (1)
  6. Norueguês  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.